Autori: Arimondo Paola B
| Naslov | Pioneering first-in-class HDAC-ROCK inhibitors as potential multitarget anticancer agents (Article) |
| Autori | Beljkas Milan Ruzic Dusan  Djuric Ana Vuletic Ana M Tchiehe Guilaine Nchugoua Jallet Corinne Cadet Daniel Veronique Arimondo Paola B Santibanez Juan Francisco Srdic-Rajic Tatjana V Nikolic Katarina M Oljacic Slavica V Petkovic Milos R
|
| Info | FUTURE MEDICINAL CHEMISTRY, (2025), vol. 17 br. 4, str. 393-407 |
| Projekat | Ministry of Science, Technological Development and Innovation, Republic of Serbia; University of Belgrade-Faculty of Pharmacy [451- 03-65/2024-03/200161, 451-03-66/2024-03/200161]; Ministry of Science, Technological Development and Innovation, Republic of Serbia; University of Belgrade-Institute for Medical Research [451-03-66/2024-03/200015]; Ministry of Science, Technological Development and Innovation, Republic of Serbia; Institute for Oncology and Radiology of Serbia [451-03-66/2024-03/200043] |
| Ispravka | Web of Science Članak Elečas Rang časopisa |
     |
| Naslov | Pioneering first-in-class HDAC-ROCK inhibitors as potential multitarget anticancer agents (Article; Early Access) |
| Autori | Beljkas Milan Ruzic Dusan Djuric Ana Vuletic Ana M Tchiehe Guilaine Nchugoua Jallet Corinne Cadet Daniel Veronique Arimondo Paola B Santibanez Juan Francisco Srdic-Rajic Tatjana V Nikolic Katarina M Oljacic Slavica V Petkovic Milos R
|
| Info | FUTURE MEDICINAL CHEMISTRY, (2025), vol. br. , str. - |
| Projekat | Ministry of Science, Technological Development and Innovation, Republic of Serbia, through Grant Agreement with University of Belgrade-Faculty of Pharmacy [451- 03-65/2024-03/200161, 451-03-66/2024-03/200161]; Ministry of Science, Technological Development and Innovation, Republic of Serbia, through Grant Agreement with University of Belgrade-Institute for Medical Research [451-03-66/2024-03/200015]; Ministry of Science, Technological Development and Innovation, Republic of Serbia, through Grant Agreement with Institute for Oncology and Radiology of Serbia [451-03-66/2024-03/200043] |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: |
|
|
| Naslov | Quinazoline-based analog of adenine as an antidote against MLL-rearranged leukemia cells: synthesis, inhibition assays and docking studies (Article) |
| Autori | Bon Corentin Barbachowska Magdalena Djokovic Nemanja Ruzic Dusan Si Yang Soresinetti Laura Jallet Corinne Tafit Ambre Halby Ludovic Nikolic Katarina M Arimondo Paola B
|
| Info | FUTURE MEDICINAL CHEMISTRY, (2022), vol. 14 br. 8, str. 557-570 |
| Projekat | Region Ile de France PhD fellowship; DIM OneHealth Investissements; Le Comite de Paris de la Ligue Contre la Cancer (Epi-Med 2020-2021); Hubert Curien Partnership Project for collaboration France-Serbia 2020-2022 (Pavle Savic 2020); EU COSTEuropean Cooperation in Science and Technology (COST) [CM1406]; Ministry of Education, Science and Technological Development of the Republic of Serbia Faculty of Pharmacy project [451-039/2021-14/200161] |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
|
|
| Naslov | Synthesis and Biological Activity of a Cytostatic Inhibitor of MLLr Leukemia Targeting the DOT1L Protein (Article) |
| Autori | Bon Corentin Si Yang Pernak Melanie Barbachowska Magdalena Levi-Acobas Eva Daniel Veronique Cadet Jallet Corinne Ruzic Dusan Djokovic Nemanja Djikic Teodora Nikolic Katarina M Halby Ludovic Arimondo Paola B
|
| Info | MOLECULES, (2021), vol. 26 br. 17, str. - |
| Projekat | Region Ile de FranceRegion Ile-de-France; DIM OneHealth Investissements; Le Comite de Paris de la Ligue contre la Cancer (project Epi-Med 2020-2021); Hubert Curien Partnership Project for collaboration France-Serbia 20202022 (Program Pavle Savic 2020); EU |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
|
|
